Multiple Pregnancies
Multiple Pregnancies
Multiple Pregnancies
Multiple Pregnancy
Pregnancy
Same Different
Genetic feature
Diagnosis
• History – Family history, H/o taking Ovulation inducing
drugs.
• Symptoms –Excessive nausea vomiting, Leg swelling,
Varicose veins, Haemorrhoids getting worse, cardio
respiratory embarrassment due to excessive
enlargement of the uterus
• Signs –
Anaemia, edema, raised BP, Abnormal weight gain.
Height of fundus and abdominal girth- more than
corresponding period of gestation Two
or more foetal head Three
or more foetal poles Two distinct
FHS heard by two observers with at least a
difference of 10 beats per minute
• Investigation- USG/x-Ray
Complications
Maternal
• Morbidity – 3-7 times increased in multiple Pregnancy
• Miscarriage
• Increased symptoms of early pregancy
• PIH - 14 – 20% (M)
- 6 – 8% (S)
• Anemia – 9% (M) vs 4% (S)-Iron, folic acid, Vit B 12,
• Preterm labour - 22 – 50% (M)
- 10% (S)
• PROM – 3 times
• Polyhydramnios- more common in uniovular twins and usually involves
the second sac.
• PPH – 20%
• Incidence of Placenta praevia/ Abruptio Placentae is more.
• Increased incidence of malpresentation
• Overall AN complications - 80% (M)
- 30% (S)
• Increased risk of operative delivery
• Postnatal problems
Complications
Fetal & Neonatal
• Mortality – 10%- Single fetal death
• PTL, PROM
• IUGR (12 – 30%), twin-twin
transfusion synd.
• Twin reversed arterial perfusion
• Stuck twin (sonographic appearance
of an extreme form of T-T
transfusion syndrome)
• Asphyxia
• Neonatal death
Complications
• Congenital anomalies – 17%
Common – cleft lip, palate,
CNS, cardiac defects
Unique – conjoined T, fetal
acardia
• Abruptio
• Cork problems – 1 – 5%
Complications
• Malpresentations:
Vx – Vx – 40%
Vx – Breech – 28%
Vx-transverse-7.5%
Breech-vx-9%
Br – Br – 6.7%
Breech – transverse-2.6%
other combinations-6.7%%
• Intrapartum complications
Birth trauma : 5 – 10%
Discordant growth (15 – 30%)
• Weight discrepancy> 20%
• After 24 weeks
• 5%- head circumference,20mm
in abdominal girth and 15-20% in
EFW
• Unequal placental mass
• Genetic syndromes
• TTS
Twin – Twin transfusion syndrome
(5-17% - monochorionic.)
• Abnormal Vascular communications (A – V)
Circulatory imbalance
Anemia Polycythemia
• Discrepancy in Hct & BW > 20%
• Donor twin- markedly smaller/less liquor/appears stuck to the
uterine wall/IUGR, Hydrops, high output failure
• Recipient –large/polyhydramnios/ cardiomegaly – CCF, IUD,
RDS
• Overall mortality-60-70%
• Single placenta
• Fetal hydrops in one/both
• U. cords differ in size
• –Mx – Bedrest
- Glucocort & PTD
- Nd-YAG laser occlusion of vascular anastomosis
Amniocentesis – polyhydramniotic sac
Single foetal demise
• Occurs in monochorionic twins
• <14 weeks-does not increase the risk of
survivor twin
• >14 weeks- risk of neurological damage of the
survivor resulting from transfer of
thromboplastin from the dead twin producing
thrombotic arterial oclussions
• Occlusion of anterior and middle cerebral
arteries cause multicystic encephalomalacia.
• Mother is at a risk of developingconsumptive
coagulopathy usually after 3 weeks
Conjoined twins
(1/200 MZ; 1/900 TB; 1/50,000LB)
1. Thoracopagus (40%)
2. Omphalo pagus (35%)
3. Pyopagus (18%)
4. Ischiopagus (6%)
5. Craniopagus (2%)
6. Surgical separation:
» Absence of malformations
» Lack of bone unions
» Separate hearts
Antepartum Mx: Frequent ANc
• Prevention of PTD – cerclage
- bedrest
- glucocorticoids
- tocolysis
- infection control
• Monitoring fetal growth
• Deciding optimal mode of delivery
• Dietetic advice-Adequate calorie intake to meet
increased demand- Supplementary iron, Vitamin,
Calcium and folic acid
• Elective Hospitalisation –Provides physical rest,
improves uteroplacental circulation, may have a
quiescent effect on uterine contractility
• More frequent visit- every 2 weeks to detect
anaemia or PIH at earliest
Management during labour
• Should be confined to tertiary
health centre(anaesthesia/NICU)
• NPO/IV fluids
• X-match the blood
• Continuous IP Foetal monitoring
• Pain releif- epidural anaesthesia
• Two neonatologists should be
present at the time of delivery.
Intrapartum management of twns
ECV/IPV/Deliver ARM/Oxytocin